US5935840AExpiredUtility
Activated recombinant adenovirus proteinases
Est. expiryJun 29, 2010(expired)· nominal 20-yr term from priority
C12N 9/503
44
PatentIndex Score
4
Cited by
42
References
3
Claims
Abstract
This application describes methods and expression constructs for producing activatable recombinant adenovirus proteinases. Purified activatable recombinant adenovirus proteinases and methods of purification are described. Activated adenovirus proteinases and methods for obtaining activated adenovirus proteinases are further included. Isolated peptide cofactors of adenovirus proteinase activity, methods of purifying and identifying said peptide cofactors are also described. Antibodies immunoreactive with adenovirus proteinases, immunospecific antibodies, and methods for preparing them are also described. Other related methods and materials are also described.
Claims
exact text as granted — not AI-modifiedwe claim:
1. A bacterial cell transformed with a plasmid selected from the group consisting of: a. pT7AD23K1; b. pT7AD23K2; c. pT7AD23K5; d. pT7AD23k6 (ATCC Deposit No. 68322); e. pT7AD23K8; f. pT7AD23K10; g. pT7AD23K11; h. pT7AD23K13; i. pT7AD23k15; j. pT7AD23K16; and k. pT7AD23K18.
2. An isolated nucleic acid having the nucleotide sequence SEQ ID NO: 39.
3. The plasmid pT7AD23K18.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.